4/9/24 18:38 | 4/7/24 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Foehr Matthew W | CA | DO | P,CEO | M.d | 0 | 0.00 | 0 | 36 | 1 | 3,170 | D | | | | | | | | | | | | | | |
3/29/24 16:52 | 3/27/24 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Foehr Matthew W | CA | DO | P,CEO | M.d | 907 | 3.72 | 0 | 244 | 8 | 3,152 | D | | | | | | | | | | | | | | |
3/25/24 07:07 | 3/22/24 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Foehr Matthew W | CA | DO | P,CEO | P | 1,168 | 5.19 | 0 | 225 | 8 | 2,909 | D | | | | | | | | | | | | | | |
2/20/24 18:22 | 2/15/24 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Foehr Matthew W | CA | DO | CEO | M.d | 0 | 0.00 | 0 | 37 | 1 | 2,684 | D | | | | | | | | | | | | | | |
1/3/24 17:42 | 1/2/24 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Foehr Matthew W | CA | DO | CEO | M.d | 0 | 0.00 | 0 | 33 | 1 | 2,665 | D | | | | | | | | | | | | | | |
12/13/23 15:25 | 12/12/23 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Foehr Matthew W | CA | DO | CEO | P | 1,010 | 5.05 | 0 | 200 | 8 | 2,645 | D | | | | | | | | | | | | | | |
12/11/23 19:24 | 12/7/23 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Foehr Matthew W | CA | DO | CEO | M.d | 0 | 0.00 | 0 | 27 | 1 | 2,445 | D | | | | | | | | | | | | | | |
11/13/23 08:00 | 11/10/23 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Foehr Matthew W | CA | DO | P,CEO | P | 406 | 4.27 | 0 | 95 | 4 | 2,428 | D | | | | | | | | | | | | | | |
8/15/23 16:56 | 8/14/23 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Foehr Matthew W | CA | DO | P,CEO | P.d | 247 | 5.48 | 0 | 45 | 2 | 2,333 | D | | | | | | | | | | | | | | |
6/12/23 16:47 | 6/9/23 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Foehr Matthew W | CA | DO | CEO | P | 520 | 4.52 | 0 | 115 | 5 | 2,574 | D | | | | | | | | | | | | | | |
5/15/23 16:02 | 5/12/23 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Foehr Matthew W | CA | DO | CEO | P | 1,496 | 3.40 | 0 | 440 | 22 | 2,438 | D | | | | | | | | | | | | | | |
12/14/22 17:00 | 12/12/22 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Foehr Matthew W | CA | DO | P,CEO | P | 565 | 3.77 | 0 | 150 | 9 | 1,838 | D | | | | | | | | | | | | | | |
12/1/22 18:00 | 11/30/22 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Foehr Matthew W | CA | DO | P,CEO | P | 1,016 | 3.39 | 0 | 300 | 21 | 1,705 | D | | | | | | | | | | | | | | |
11/9/22 20:30 | 11/9/22 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Foehr Matthew W | CA | DO | P,CEO | P | 276 | 2.76 | 0 | 100 | 8 | 1,405 | D | | | | | | | | | | | | | | |
5/13/22 19:05 | 5/13/22 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | P | 207 | 82.76 | 0 | 3 | 1 | 173 | D | | | | | | | | | | | | | | |
5/3/22 16:12 | 5/2/22 | VKTX | Viking Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | D | | P | 111 | 2.47 | 0 | 45 | 68 | 111 | D | | | | | | | | | | | | | | |
11/12/21 16:54 | 11/11/21 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | M.d | 348 | 28.54 | 0 | 12 | 8 | 167 | D | | | | | | | | | | | | | | |
11/12/21 16:54 | 11/11/21 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | S.d | -1,819 | 163.02 | 0 | -11 | -6 | 167 | D | | | | | | | | | | | | | | |